What type of study is this?

This is a Human Clinical Trial study (also classified as: RCT).

February 26, 2026Open Access

Vaginal pixel CO2 laser versus topical use of promestriene for genitourinary syndrome of menopause

Key Points

To compare the effectiveness of pixel CO2 laser and vaginal promestriene in treating genitourinary syndrome of menopause.
Quasi-randomized controlled trial conducted with 48 patients
CO2 Laser Group received 3 sessions of vaginal pixel CO2 laser
Promestriene group used vaginal promestriene daily for 14 days.
The CO2 laser was found to improve symptoms of GSM more effectively than promestriene.

Abstract

Objective: To compare the effectiveness of pixel CO2 laser and vaginal promestriene in treating genitourinary syndrome of menopause (GSM). Methods: A quasi-randomized controlled trial was conducted with 48 patients. CO2 Laser Group (24 patients) received 3 sessions of vaginal pixel CO2 laser, and promestriene group (24 patients) used vaginal promestriene daily for 14 days, …

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Beckhauser et al. (Thu,) studied this question.

synapsesocial.com/papers/699f95a81bc9fecf3dab39db https://doi.org/https://doi.org/10.61622/rbgo/2026rbgo13

Bookmark

View Full Paper